Clinical Trial Update: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether Brivaracetam reduces nonpsychotic behavioral side effects in epilepsy patients previously treated with Levetiracetam; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)
• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2016-08-15